Earnings Miss: Eckert & Ziegler SE Missed EPS By 29% And Analysts Are Revising Their Forecasts

Eckert & Ziegler SE (ETR:EUZ) last week reported its latest annual results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. Statutory earnings per share fell badly short of expectations, coming in at €0.78, some 29% below analyst forecasts, although revenues were okay, approximately in line with analyst estimates at €312m. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. We’ve gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

Taking into account the latest results, the most recent consensus for Eckert & Ziegler from three analysts is for revenues of €322.5m in 2026. If met, it would imply a reasonable 3.4% increase on its revenue over the past 12 months. Per-share earnings are expected to rise 7.5% to €0.84. Yet prior to the latest earnings, the analysts had been anticipated revenues of €341.9m and earnings per share (EPS) of €0.88 in 2026. It’s pretty clear that pessimism has reared its head after the latest results, leading to a weaker revenue outlook and a minor downgrade to earnings per share estimates.

View our latest analysis for Eckert & Ziegler

Despite the cuts to forecast earnings, there was no real change to the €22.43 price target, showing that the analysts don’t think the changes have a meaningful impact on its intrinsic value. The consensus price target is just an average of individual analyst targets, so – it could be handy to see how wide the range of underlying estimates is. Currently, the most bullish analyst values Eckert & Ziegler at €24.00 per share, while the most bearish prices it at €20.30. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Eckert & Ziegler’s past performance and to peers in the same industry. It’s pretty clear that there is an expectation that Eckert & Ziegler’s revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 3.4% growth on an annualised basis. This is compared to a historical growth rate of 13% over the past five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 5.5% per year. So it’s pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Eckert & Ziegler.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Unfortunately, they also downgraded their revenue estimates, and our data indicates underperformance compared to the wider industry. Even so, earnings per share are more important to the intrinsic value of the business. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company’s earnings is a lot more important than next year. We have forecasts for Eckert & Ziegler going out to 2028, and you can see them free on our platform here.

We also provide an overview of the Eckert & Ziegler Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.